Omada Health’s Prevent program has enrolled nearly 55,000 patients since its start in 2012, and has been demonstrating successful, real-world applicable results for patients with pre-diabetes, said Mike Payne, MBA, MSci, chief healthcare development officer at Omada Health.
Omada Health’s Prevent program has enrolled nearly 55,000 patients since its start in 2012, and has been demonstrating successful, real world applicable results for patients with pre-diabetes, said Mike Payne, MBA, MSci, chief healthcare development officer at Omada Health.
Transcript (slightly modified)
What is the Omada Health Prevent program and what have been the outcomes so far?
The outcomes have kind of exceeded our expectations, amazingly. We have been treating people since about 2012. We’ve put about 55,000 patients so far into the program, so starting to get to a pretty big sample size but we have big ambitions to drive that into the millions given the size of the epidemic. And, there’s a lot of clinical trial work that’s been done in the diabetes prevention program space. So, we have good yardsticks to compare it by.
And so far for us, we’re seeing results in terms of weight loss, biomarkers like hemoglobin A1c, which tracks blood sugar control, that are quite similar to what was seen in a variety of clinical trials. And so the thing that we’re most pleased about is, unlike a lot of other areas of medicine where the results in the clinical trials were far better than what the results look like in the real world, we’re achieving close to clinical trial results on an on-going basis, in the real world with massive quantities of patients. And so for us, that’s really encouraging that we can not only do this in a controlled environment but we may be able to scale this to a level that’s needed, and that’s 28 million seniors and 87 million total adults in the US with pre-diabetes.
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More